dual mitosis/angiogenesis inhibitors (Roche)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual mitosis/angiogenesis inhibitors (Roche)
Drug Alias NameMAI inhibitors (Roche)RO-0281501
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell cycle inhibitorsAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoffmann-La Roche Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoffmann-La Roche Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A